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Natural killer (NK) cells play key roles in innate and adaptive 
immune defenses.  NK cell responses are mediated by two 
major mechanisms: the direct cytolysis of target cells, and 
immune regulation by production of various cytokines.  Many 
previous reports show that the complex NK cell activation 
process requires de novo gene expression regulated at both 
transcriptional and post-transcriptional levels.  Specialized 
un-translated regions (UTR) of mRNAs are the main mecha-
nisms of post-transcriptional regulation. Analysis of post- 
transcriptional regulation is needed to clearly understand NK 
cell biology and, furthermore, harness the power of NK cells 
for therapeutic aims.  This review summarizes the current un-
derstanding of mRNA metabolism during NK cell activation, 
focusing primarily on post-transcriptional regulation.
[Immune Network 2009;9(4):115-121]
INTRODUCTION
N K  c e l l s  a r e  l a r g e  g r a n u l a r  l y m p h o c y t e s  i n v o l v e d  i n  p r o -
tection  against  infectious  microbial  pathogens  and  tumors. 
They are found throughout the body in both non-lymphoid 
peripheral tissues and lymphoid organs. Unlike B and T lym-
phocytes  which  express  somatically  rearranged  antigen-spe-
cific receptors, NK cells express receptors to recognize and 
respond  to  an  array  of  infected  or  tumorigenic  cells  (1). 
Decades of work have resulted in a substantial gain in under-
standing of what and how NK cells are regulated before they 
kill target cells, lending important insights into their gene reg-
ulation  mechanisms  for  immune  regulation  and  cytotoxicity 
(Fig.  1).
    NK cells actively respond to environmental changes by reg-
ulating de novo gene expression, which is strictly controlled 
by four-step-expression. Four-step-expression is synthesis and 
degradation of mRNA together with synthesis and degradation 
of  the  corresponding  proteins  (2).  Fine  tuning  of  synthesis 
and  degradation  rates  is  not  only  essential  for  maintaining 
protein levels, but also allows for fast and sensitive responses 
to target cells. In contrast to B and T cells, the post-transcrip-
tional mechanisms governing NK cell activation remain poorly 
understood. However, there are some examples of post-tran-
scriptional  gene  regulation  during  the  trafficking,  immune 
synapse  formation, cytokine  production,  and  cytolysis  steps 
of NK cell responses (Table I). This review focuses on possi-
ble regulatory mechanisms of mRNA stability and translation 
during  NK  cell  activation. 
Urokinase plasminogen activator (uPA) and uPA 
receptor (uPAR)
The uPA system has been shown to play a major role in the 
extravasation  and  migration  of  leukocytes  into  areas  of 
inflammation. One unique feature of the uPA system is the 
presence of a specific cellular receptor for uPA, the uPA re-
ceptor  (uPAR),  which  is  involved  in  cell  migration  and  in-
vasion, independent of its role in the proteolytic pathways. 
uPAR  has  been  shown  to  be  involved  in  cellular  adhesion 
by  its  ability  to  bind  to  the  extracellular  matrix  protein 
vitronectin. uPAR also has the capacity to initiate secondary 
signaling  pathways  through  its  interactions  with  integrins, 
thereby  promoting  cellular  movement  and  migration  (3). 
    The  regulation  of  uPA  and  uPAR  expression  occurs  at  a 
post-transcriptional level through mRNABPs that bind to the 
3’-UTR.  Heterogeneous  nuclear  ribonuclear  protein  C1 
(hnRNP C1) and HuR bind to the uPA 3’-UTR, which leads 
to uPA mRNA stabilization (4). Similarly, hnRNP C1 binds to 
a 110-nucleotide sequence of the uPAR mRNA 3’-UTR, there-
by preventing its degradation (5). Conversely, p53 decreased Post-transcriptional Regulation of NK Cell Activation
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Table I. Post-transcriptional gene regulation during NK cell activation
Process mRNA Cis-acting element Trans-acting factor Function
Trafficking uPA and uPAR 3'-UTR hnRNP C1/HuR Increase mRNA stability (4)
p53 Decrease mRNA stability (6,7)
Immune synapse MICA and MICB 3'-UTR Viral miRNA Decrease mRNA translation (10)
Cellular miRNAs Decrease mRNA translation (11)
Cytotoxicity Prf1 and GzmB Unknown Unknown Translational control (14)
Cytokine production IFN-γ ARE TTP Decrease mRNA stability (17,18)
GM-CSF ARE hnRNP D and TTP Decrease mRNA stability (23)
HuR Increase mRNA stability (26)
5'- UTR unknown Increase mRNA translation (29,30)
IL-10 ARE P40 hnRNP D Increase mRNA stability (33,34)
hnRNP D Decrease mRNA stability (35)
3'- UTR miR-106a Decrease mRNA translation (35)
TNF-α ARE TTP Decrease mRNA stability (38-41)
HuR Increase mRNA stability (38-41)
TIA-1 and TIAR Decrease mRNA translation (42,43)
MIP-1α 3'- UTR Unknown Decrease mRNA stability (44)
ARE: AU-rich element in the 3'- UTR, miRNA: microRNA, UTR: Un-translated region, uPA: urokinase plasminogen activator, uPAR: uPA 
receptor, hnRNP: heterogeneous nuclear ribonuclear protein, MIP-1α: Macrophage inflammatory protein-1α, TNF: Tumor necrosis 
factor, GM-CSF: Granulocyte-macrophage colony-stimulating factor, TIAR: TIA-related protein, TIA: T-cell restricted intracellular 
antigen, TTP: Tristetraprolin, Prf1: Perforin, GzmB: Granzyme B
Figure 1. The NK cell immune response.
NK cells play a role in the direct 
cytolysis of target cells and immune 
regulation by cytokine production. NK 
cell activation requires de novo gene 
expression regulated at both transcrip-
tional and post-transcriptional levels, 
which are governed by four-step-expres-
sion, specifically the synthesis and 
degradation of mRNA together with 
synthesis and degradation of the 
corresponding proteins. NA: Nucleic 
acids, AA: Amino acids.
b o t h  u P A  a n d  u P A R  m R N A  s t a b i l i t y  b y  b i n d i n g  t o  a  
35-nucleotide  sequence  in  the  uPA  3’- U T R  a n d  a  
37-nucleotide sequence in the uPAR 3’-UTR, resulting in de-
creased cellular expression. p53-deficient (p53
−/−) lung car-
cinoma  cells  express  robust  levels  of  cell  surface  uPA  and 
uPAR mRNA, thereby contributing to human airway epithelial 
or  lung  carcinoma  cell  viability  (6,7).
  A recent study showed that NK cells expressed both uPA Post-transcriptional Regulation of NK Cell Activation
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and uPAR and that in vitro NK cells employ the uPA system 
following stimulation with IL-2. uPA and uPAR mRNA binding 
proteins (mRNABPs) were also detected in NK cells. Increases 
in  uPA and uPAR  following IL-2  stimulation,  correspond  to 
changes in uPA and uPAR mRNA-mRNABP interactions. The 
upregulation of uPA and uPAR may partially explain the in-
creased  NK  cell  invasiveness  following  IL-2  treatment  (8).
NKG2D ligands
An encounter between an immune cell and another host cell 
may result in the generation of an immune synapse, a speci-
alized interface at the cell-cell contact point. Immunological 
synapses  (IS),  as  described  by  Davis,  are  contacts between 
two cells, at least one of them being a cell of the immune 
system, such as NK cells, that results in segregation of pro-
teins at the cell-cell interface into micrometer-scale three-di-
mensional domains (9). NK cell activation is controlled by a 
dynamic  balance  between  stimulatory  and  inhibitory  path-
ways that are initiated upon interactions with potential target 
cells (1). NKG2D is one of the best characterized activating 
receptors found on NK and CD8
＋ T cells. This receptor rec-
ognizes  several  different  ligands  (MHC  class  1  polypep-
tide-related  sequence  A/b  [MICA/B]  and  UL16-binding  pro-
teins  [ULBPs])  induced  by  cellular  stress  and  infection. 
NKG2D-ligand engagement activates NK cells and drives cyto-
t o x i c i t y  a g a i n s t  t h e  t a r g e t  c e l l s  ( 9 ) .
    MICA and MICB are stress-induced ligands recognized by 
the  activating  receptor  NKG2D.  Recently,  Mandelboim  and 
colleagues  reported  MICA/B-targeting  of  viral  and  cellular 
microRNAs (miRNAs). The miRNA hcmv-miR-UL112 encoded 
by human cytomegalovirus down-regulates MICB expression 
by targeting  a  specific site  in the MICA and  MICB 3’-UTRs 
during viral infection. The down-regulation of MICB leads to 
decreased  binding  of  NKG2D  and  reduced  killing  by  NK 
c e l l s .  N o t a b l y ,  t h i s  i s  a  n o v e l  v i r a l  i m m u n o e v a s i o n  m e c h a -
nism based on miRNA regulation (10). Furthermore, a group 
of endogenous cellular miRNAs (miR-106b, -20a, -373, -520d, 
and -93) that bound to the MICA and MICB 3’-UTR sequences 
was identified. These miRNAs share the mRNA target site with 
the  viral  miRNA  hcmv-miR-UL112.  These  miRNAs  repress 
MICA/B under normal conditions to maintain their expression 
under a certain threshold and they facilitate acute upregula-
tion  of  MICA/B  during  cellular  stress  (11).
Granzyme B and perforin
When a fully primed NK cell recognizes a target cell, an IS 
is formed between the two cells. Cytotoxic granules within 
the NK cells move toward the synapse, fuse with the plasma 
membrane, and release their contents into the synaptic cleft. 
Perforin then facilitates the delivery of granzymes into the cy-
tosol  of  the  target  cell,  where  a  variety  of  substrates  are 
cleaved to initiate cell death (12). Serine protease granzymes 
are key NK cell effector molecules, but their regulation remains 
largely undefined. Granzyme B, the most thoroughly charac-
terized of the granzymes, cleaves a variety of procaspases, BID, 
inhibitor  of  caspase-activated  DNase,  and  other  intracellular 
substrates  to  initiate  classical  apoptotic  pathways  (13). 
    Resting NK cells are minimally cytotoxic against tumor tar-
get cells in vitro. Cytokine-induced in vitro activation of NK 
cells results in potent killing associated with a dramatic in-
crease in granzyme B and perforin, with minimal changes in 
corresponding  mRNA  abundance.  This  suggests  that  resting 
NK cells are “pre-armed” with high amounts of granzyme B 
and perforin mRNA. Both mRNAs are repressed during nor-
mal mRNA translation, but are released by cellular activation 
[14]. Furthermore, it is thought that this unknown mechanism 
is an efficient arming process for cytolytic immune cells, and 
allows for fast and sensitive responses to target cells during 
NK  cell  activation.
Interferon-γ
IFN-γ has been extensively studied and has been found to 
profoundly affect a variety of immune responses. These in-
clude upregulation of major histocompatibility complex class 
I and II expression, proliferation and differentiation of lym-
phocyte populations, and induction of genes that code for im-
munomodulatory proteins, such as tumor necrosis factor al-
pha (TNFα) and nitric oxide synthase. T and NK cells are 
the primary cellular producers of IFN-γ. In NK cells, IFN-γ 
production is triggered by interactions with target cells, such 
as tumor or virally infected cells, or by a variety of cytokines, 
such as interleukin-2 (IL-2) and IL-12. These cytokines can act 
independently to induce IFN-γ expression. However, togeth-
er they act synergistically to induce large amounts of IFN-γ. 
The  kinetics  of  IFN-γ expression  results  from  both  tran-
scription  and  rapid  degradation  of  IFN-γ mRNA  (15). 
    As with many cytokine mRNAs, IFN-γ mRNA contains an 
AU-rich element (ARE) in its 3’-UTR. AREs have been identi-
fied in the 3’-UTR of a variety of labile mRNAs, and are well 
known to lead to decreases in the half-life of corresponding 
target genes. ARE-binding proteins as trans-acting factors in-
clude  members  of  the  Hu  protein  family  HuR,  hnRNP  D Post-transcriptional Regulation of NK Cell Activation
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(AUF1),  tristetraprolin  (TTP),  the  K  homology-type  splicing 
regulatory  protein  (KSRP),  the  T-cell  restricted  intracellular 
antigen (TIA)-1, and TIA-related protein (TIAR) (16). IFN-γ 
mRNA degradation is mediated by TTP and a 70-nucleotide 
AU-rich sequence in its 3’-UTR. TTP knock-out mice showed 
overexpression of IFN-γ due to stabilization of the IFN-γ 
mRNA, suggesting that TTP plays an important role in turning 
off IFN-γ expression at the appropriated time during an im-
mune  response  (17,18).  Likewise,  IFN-α and  -β mRNAs 
contain AREs and are subject to mRNA destabilization (19,20).
Granulocyte-macrophage colony-stimulating factor 
(GM-CSF)
Granulocyte-macrophage  colony-stimulating factor  (GM-CSF) 
is a multifunctional cytokine currently used for the reversal 
of  neutropenia  associated  with  bone  marrow  and  haemo-
poietic stem cell transplantation and chemotherapy. GM-CSF 
also  modulates  the  function  of  differentiated  white  blood 
cells. In local inflammatory responses, GM-CSF stimulates an-
timicrobial  and  antitumor  effects  of  macrophages.  GM-CSF 
further enhances healing by its actions on fibroblasts and epi-
dermal cells. GM-CSF may enhance antibody dependent cel-
lular cytotoxicity (ADCC) in several cell types and cytotoxicity 
of NK cells. GM-CSF may be useful for inducing or augment-
ing antibody responses to antimicrobial vaccines, to enhance 
killing of intracellular microorganisms, to accelerate epidermal 
and mucosal wound healing, and to stimulate protective im-
munity  against  tumors  (21).  In  multiple  murine  models, 
GM-CSF  proved  to  be  the  most  potent  immunostimulatory 
molecule  (22). 
    Degradation of the ARE-containing GM-CSF mRNA is accel-
erated in vitro by protein fractions enriched for hnRNP D, an 
ARE-specific binding factor (23). hnRNP D is broadly involved 
in mRNA decay (24,25). HuR, a ubiquitously expressed mem-
ber of the Elav family of RNA binding proteins, exhibits spe-
cific  affinities  for  ARE-containing  RNA  sequences  in  vitro, 
which correlates with their in vivo decay rates. Overexpres-
sion  of  HuR  enhances  the  stability  of  GM-CSF  mRNA  (26). 
Enzymes  involved  in  all  three  of  these  mRNA  decay  proc-
esses,  as  well  as  5’-to-3’  exonucleolytic  decay,  include  the 
protein TTP and its homolog BRF-1, which bind to GM-CSF 
ARE and activate mRNA decay. The TTP family functions as 
a molecular link between ARE-containing mRNAs and mRNA 
decay  machinery  by  recruiting  mRNA  decay  enzymes.  The 
TTP protein family also helps to explain how deadenylation, 
decapping,  and  exonucleolytic  decay  can  be  independently 
activated  on  ARE-containing  mRNAs  (27,28).
  Interestingly, the GM-CSF ARE has also been shown to con-
trol translation  in vitro. In the absence of a native 5’-UTR, 
the  ARE  and  poly  (A)  tail  act  in  concert  to  block  GM-CSF 
mRNA translation. Substitutions of different regions of the na-
tive 5'-UTR revealed that the entire sequence was essential 
in maintaining the highest rates of translation. The 5’-UTR is 
highly  conserved,  suggesting  similar  regulation  in  multiple 
species.  The  5’-UTR  is  the  dominant  element  regulating 
GM-CSF mRNA translation, overriding the inhibitory effects of 
the  ARE  and  the  poly  (A)  tail  (29,30).
Interleukin-10 (IL-10)
IL-10 has been shown to be anti-inflammatory in many model 
systems. Deregulation of IL-10 leads to various immunological 
diseases, such as cancer, rheumatoid arthritis, asthma, and in-
fectious disorders. Therefore, it is likely that IL-10 expression 
is  tightly  regulated  at  the  transcriptional  and  posttranscrip-
tional levels (31). Recently, it has been reported that NK cells 
are the major source of murine IL-10, as compared with help-
er T cells. The inhibitory effect of NK cells are only acquired 
later during infection, coincident with increased IL-10 mRNA 
stability and an enhanced capacity to secrete IL-10 protein. 
This  suggests  that  post-transcriptional  regulation  of  IL-10 
mRNA  is  involved  in  the  inhibitory  function  of  NK  cells. 
However, the detailed molecular mechanisms have yet to be 
elucidated  (32). 
    The availability of IL-10 protein is significantly determined 
by  post-transcriptional  mechanisms.  ARE  in  the  3’-UTR  of 
IL-10  are  involved  in  its  translational  regulation.  Adenosine 
receptor ligands have anti-inflammatory effects and modulate 
immune  responses  by  inducing  IL-10  production  by  im-
munostimulated macrophages. Adenosine receptor activation 
acts by relieving the translational repressive effect of the IL-10 
3’-UTR. Adenosine enhanced binding of proteins to a region 
of the IL-10 3’-UTR containing the GUAUUUAUU nonamer. 
During  lipopolysaccharide  (LPS)  stimulation  of  THP-1  cells, 
the p40 hnRNP D isoform binds to the IL-10 3’-UTR and se-
lectively induces IL-10 expression (33,34). Interaction of AREs 
in the 3’-UTR of IL-10 mRNA with hnRNP D leads to the deg-
radation  of  IL-10  mRNA  (35).
    Moreover, a miRNA, hsa-miR-106a, that regulates IL-10 ex-
p r e s s i o n  w a s  r e p o r t e d .  h s a - m i R -106a  directly  binds  to  the 
IL-10 3’-UTR to repress translation. Also, the transcription fac-
t o r s  S p 1  a n d  E g r 1  h a v e  a n  i m p o r t a n t  r o l e  i n  h s a - m i R - 1 0 6 a  
transcription and, thus, indirectly regulates the expression of Post-transcriptional Regulation of NK Cell Activation
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IL-10  at  the  post-transcriptional  level  (36).
Tumor necrosis factor alpha (TNF-α) 
TNF-α, initially discovered as a result of its antitumor activ-
ity, is a critical component of effective immune surveillance 
and is required for proper proliferation and function of NK 
cells, T cells, B cells, macrophages, and dendritic cells (37). 
Post-transcriptional  regulation  and  stability  is  important  for 
TNF-α expression, as TNF-α mRNA contains an ARE in the 
3’-UTR.  Regulation  of  TNF-α mRNA  turnover  has  been 
shown to be mediated by the trans-acting proteins TTP and 
HuR, which bind the ARE and destabilize or stabilize the tran-
script, respectively (38-41). Among TNF-α ARE-binding pro-
t e i n s ,  T I A - 1  a n d  T I A R  a c t  a s  T N F - α mRNA  translational 
silencers.  In  unstimulated  immune  cells,  TNF-α mRNA  is 
translationally  repressed  and  becomes  efficiently  translated 
upon  cellular  activation  (42,43). 
Macrophage inflammatory protein-1α (MIP-1α) 
MIP-1α, a chemotactic pro-inflammatory cytokine, is also se-
creted by NK cells. MIP-1α is a chemoattractant for mono-
cytes and neutrophils and, thus, plays an important role in 
initiation and control of inflammation. In resting RAM cells, 
MIP-1α mRNA decayed rapidly with a half life of less than 
2 hours. LPS treatment of RAM cells resulted in a dose-de-
pendent  increase  in  MIP-1α mRNA  expression.  The  in-
duction of MIP-1α mRNA by LPS was partially the result of 
mRNA stabilization, as half life increased to over 6 hours (44). 
Although the detailed molecular mechanism has not been de-
fined, ARE-mediated mRNA degradation might be involved in 
the mRNA destabilization of MIP-1α, similar to those of other 
cytokine  mRNAs.
CONCLUSION
Each step of NK cell activation is controlled by post-transcrip-
tional gene regulation. Specifically, components of the uPA 
system, NKG2D ligands, and the cytokines IFN-γ, GM-CSF, 
IL-10,  TNF-α,  and  MIP-1α are  post-transcriptionally  regu-
lated, mainly by mRNA stabilization/destabilization or transla-
tional control. These control mechanisms are not only essen-
tial for maintaining proper protein levels, but also allow for 
fast  and  sensitive  responses  of  NK  cells  to  target  cells. 
    Although the role of noncoding RNAs in immune responses 
is an emerging hot topic, the regulation of NK cell functions 
is  poorly  understood.  Moreover,  few  studies  on  post-tran-
scriptional regulation during NK cell development have been 
reported.  A  better  understanding  of  gene  regulation  at  the 
post-transcriptional  level  during  NK  cell  differentiation  and 
activation  may  assist  in  the  development  of  novel  NK  cell- 
based  immunotherapies  for  major  human  diseases.
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